Aperture Investors Closes $300MM Asset-Based Financing Facility with Avant
Aperture Investors, an alternative asset manager and part of Generali Investments, led a $300 million asset-based financing facility with Avant,...
Forward for Specialty Finance
Discovery Increases and Extends Revolving Credit Facility
Discovery Mining amended the company’s senior secured revolving credit facility, increasing the total commitments, extending the maturity, improving pricing and...
Celtic Capital Provides $3MM A/R Line of Credit for New Clients
Celtic Capital’s most recent client relationship is two Pacific-based companies under common ownership. The first repurposes pre-consumer organic waste and...
SouthStar Capital Closes $500K Invoice Factoring Facility for Arizona-Based Chemical Supplier
SouthStar Capital, a provider of commercial financing solutions, closed a $500,000 invoice factoring facility for an Arizona-based supplier of EPA-registered...
Hyper Valuation Services Hires Evans as Managing Director of Business Development
Hyper Valuation Services (HVS), a division of HYPERAMS, hired Adam Evans as managing director of business development. In his new...
Greenberg Traurig Adds Corporate Tax Shareholder Morozov in California
Global law firm Greenberg Traurig expanded its tax practice with the addition of shareholder Zakhar “Zak” Morozov in the San...
Womble Expands Tax Capabilities in Baltimore
Womble Bond Dickinson added Timothy Wagner to its Baltimore office as a partner in the corporate and securities practice group....
Woodsboro Bank Grows Commercial Banking with Increased Lending Limit & Team Expansion
Woodsboro Bank, a long-standing community bank in Frederick County, expanded its commercial banking capabilities. The growth is attributed to the...
Alkami Expands Partnership with Plaid to Deliver Connected Digital Banking Experiences
Alkami Technology, a digital sales and service platform provider for financial institutions in the U.S., expanded its partnership with Plaid,...
Annexon Secures Strategic Credit Facility for Up to $200MM from Oxford Finance
Annexon, a biopharmaceutical company advancing the next generation platform of targeted immunotherapies for multiple neuroinflammatory diseases that impact nearly 10...
